3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Pain
2
Breast Neoplasms
2
Pain, Intractable
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Lymphoma
1
Leiomyoma
1
Hot Flashes
1
Breast Cancer Patient
1
Bone Neoplasms
1
Interventions
Zoledronic Acid
2
Vincristine
2
Temozolomide
2
Radiosurgery
2
Magnetic Resonance Spectroscopy
2
Irinotecan
2
Doxorubicin
2
Cyclophosphamide
2
selinexor
1
saracatinib
1
samarium Sm-153 lexidronam
1
robatumumab
1
pembrolizumab
1
pegfilgrastim
1
angiotensin I (1-7)
1
Transcranial Direct Current Stimulation
1
Tranexamic Acid
1
Sunitinib
1
Standard of Care
1
Sodium Pertechnetate Tc 99m
1
Sodium Chloride
1
Samarium
1
Radiation
1
Proton Therapy
1
Pregabalin
1
Practice Guidelines as Topic
1
Plicamycin
1
Palliative Care
1
Nivolumab
1
Neutrons
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Bone Neoplasms
×
Pregabalin
×
Clear all
NCT00381095
2021-01-20
COPE
Pfizer
Phase 4
Terminated
152 enrolled
14 charts